Literature DB >> 2829740

Activation of the Ca2+-ATPase of human erythrocyte membrane by an endogenous Ca2+-dependent neutral protease.

K K Wang1, A Villalobo, B D Roufogalis.   

Abstract

Limited proteolysis of the plasma membrane calcium transport ATPase (Ca2+-ATPase) from human erythrocytes by trypsin produces a calmodulin-like activation of its ATP hydrolytic activity and abolishes its calmodulin sensitivity. We now demonstrate a similar kind of activation of the human erythrocyte membrane Ca2+-ATPase by calpain (calcium-dependent neutral protease) isolated from the human red cell cytosol. Upon incubation of red blood cell membranes with purified calpain in the presence of Ca2+ the membrane-bound Ca2+-ATPase activity was increased and its sensitivity to calmodulin was lost. In contrast to the action of other proteases tested, proteolysis by calpain favors activation over inactivation of the Ca2+-ATPase activity, except at calpain concentrations more than 2 orders of magnitude higher. Exogenous calmodulin protects the Ca2+-ATPase against calpain-mediated activation at concentrations which also activate the Ca2+-ATPase activity. Calcium-dependent proteolytic modification of the Ca2+-ATPase could provide a mechanism for the irreversible activation of the membrane-bound enzyme.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2829740     DOI: 10.1016/0003-9861(88)90498-5

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  20 in total

1.  Demonstration of calmodulin-sensitive calcium translocation by isolated osteoclast plasma membrane vesicles.

Authors:  P J Bekker; C V Gay
Journal:  Calcif Tissue Int       Date:  1992-10       Impact factor: 4.333

2.  An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective.

Authors:  K K Wang; R Nath; A Posner; K J Raser; M Buroker-Kilgore; I Hajimohammadreza; W Probert A; F W Marcoux; Q Ye; E Takano; M Hatanaka; M Maki; H Caner; J L Collins; A Fergus; K S Lee; E A Lunney; S J Hays; P Yuen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

3.  Chlorpromazine and dimethyl sulfoxide modulate the catalytic activity of the plasma membrane Ca2+-ATPase from human erythrocyte.

Authors:  Fernando Plenge-Tellechea; Carlos A Domínguez-Solís; Ángel G Díaz-Sánchez; David Meléndez-Martínez; Javier Vargas-Medrano; Jorge A Sierra-Fonseca
Journal:  J Bioenerg Biomembr       Date:  2018-01-08       Impact factor: 2.945

4.  Structure--function relationship of the human erythrocyte plasma membrane Ca(2+)-ATPase revealed by V8 protease treatment.

Authors:  K K Wang; B D Roufogalis; T H Kuo
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

Review 5.  Recent advances in the molecular characterization of plasma membrane Ca2+ pumps.

Authors:  E E Strehler
Journal:  J Membr Biol       Date:  1991-02       Impact factor: 1.843

6.  Ca(2+)-ATPase pump forms and an endogenous inhibitor in bovine brain synaptosomes.

Authors:  I Panfoli; L Musante; A Morelli; S Thellung; A Cupello
Journal:  Neurochem Res       Date:  1997-03       Impact factor: 3.996

Review 7.  Calmodulin-binding proteins as calpain substrates.

Authors:  K K Wang; A Villalobo; B D Roufogalis
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

8.  Phosphatidylethanol stimulates the plasma-membrane calcium pump from human erythrocytes.

Authors:  M Suju; M Davila; G Poleo; R Docampo; G Benaim
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

9.  Calpain I activates Ca2+ transport by the reconstituted erythrocyte Ca2+ pump.

Authors:  K K Wang; B D Roufogalis; A Villalobo
Journal:  J Membr Biol       Date:  1989-12       Impact factor: 1.843

10.  Effects of paraquat-induced oxidative stress on the neuronal plasma membrane Ca(2+)-ATPase.

Authors:  Asma Zaidi; Denzyl Fernandes; Jennifer L Bean; Mary L Michaelis
Journal:  Free Radic Biol Med       Date:  2009-08-26       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.